Form CORRESP - Correspondence:
SEC Accession No. 0001641172-25-019539
Filing Date
2025-07-14
Accepted
2025-07-14 17:06:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10221
  Complete submission text file 0001641172-25-019539.txt   11281
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)